X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (269) 269
rheumatology (209) 209
female (127) 127
male (120) 120
middle aged (101) 101
rheumatoid arthritis (90) 90
adult (86) 86
scleroderma (79) 79
aged (69) 69
systemic sclerosis (63) 63
animals (61) 61
arthritis (52) 52
immunology (48) 48
arthritis, rheumatoid - pathology (43) 43
medicine & public health (42) 42
mice (42) 42
disease (41) 41
systemic scleroderma (41) 41
synovial membrane - pathology (40) 40
expression (39) 39
rheumatoid-arthritis (37) 37
arthritis, rheumatoid - metabolism (36) 36
inflammation (36) 36
fibroblasts (35) 35
scleroderma, systemic - complications (35) 35
abridged index medicus (33) 33
fibroblasts - metabolism (33) 33
research (33) 33
synovial membrane - metabolism (32) 32
treatment outcome (32) 32
cells, cultured (31) 31
arthritis, rheumatoid - immunology (26) 26
immunohistochemistry (26) 26
cytokines (25) 25
internal medicine (25) 25
care and treatment (24) 24
mice, scid (24) 24
risk factors (24) 24
clinical trials (23) 23
patients (23) 23
severity of illness index (23) 23
arthritis, rheumatoid - genetics (22) 22
double-blind (22) 22
osteoarthritis (22) 22
rheumatic diseases (22) 22
rheumatoid factor (22) 22
scleroderma, systemic - pathology (22) 22
fibroblasts - pathology (21) 21
skin (21) 21
studies (21) 21
antirheumatic agents - therapeutic use (20) 20
cells (20) 20
clinical medicine (20) 20
synovial membrane - cytology (20) 20
arthritis, rheumatoid - drug therapy (19) 19
autoantibodies (19) 19
fibrosis (19) 19
mortality (19) 19
arthritis, rheumatoid - therapy (18) 18
autoimmune diseases (18) 18
collagen-induced arthritis (18) 18
methotrexate (18) 18
physiological aspects (18) 18
scleroderma, systemic - physiopathology (18) 18
treatment (18) 18
analysis (17) 17
arthritis, rheumatoid - physiopathology (17) 17
disease progression (17) 17
gene expression (17) 17
synovial fibroblasts (17) 17
diagnosis (16) 16
eular scleroderma trials (16) 16
immunology and allergy (16) 16
pathogenesis (16) 16
rna, messenger - metabolism (16) 16
medicine (15) 15
necrosis-factor-alpha (15) 15
reumatologi och inflammation (15) 15
rheumatology and autoimmunity (15) 15
time factors (15) 15
classification (14) 14
databases, factual (14) 14
europe (14) 14
hypertension (14) 14
musculoskeletal diseases (14) 14
prospective studies (14) 14
scleroderma, systemic - diagnosis (14) 14
skin and connective tissue diseases (14) 14
survival (14) 14
usage (14) 14
610 medicine & health (13) 13
case-control studies (13) 13
drug therapy (13) 13
gene-expression (13) 13
health aspects (13) 13
in situ hybridization (13) 13
joint destruction (13) 13
medical and health sciences (13) 13
medicin och hälsovetenskap (13) 13
medicine, general & internal (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the rheumatic diseases, ISSN 0003-4967, 2014, Volume 73, Issue 7, pp. 1340 - 1349
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10038, pp. 2630 - 2640
Summary Background Systemic sclerosis is a rare disabling autoimmune disease with few treatment options. The efficacy and safety of tocilizumab, an interleukin... 
Internal Medicine | Medicine(all) | Multicenter Study | Clinical Trial, Phase II | Randomized Controlled Trial | Research Support, Non-U.S. Gov't | Journal Article | INTERSTITIAL LUNG-DISEASE | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | PLACEBO | LYSOPHOSPHATIDIC ACID | DIFFUSE SCLERODERMA | SKIN FIBROSIS | INTERLEUKIN-6 | EXPRESSION | SSC SKIN | Biomarkers - metabolism | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Europe | Humans | Middle Aged | Scleroderma, Systemic - metabolism | Male | Treatment Outcome | United Kingdom | Canada | Vital Capacity | Antibodies, Monoclonal, Humanized - administration & dosage | Injections, Subcutaneous | Scleroderma, Systemic - complications | Interleukin-6 - physiology | Adult | Female | Aged | Scleroderma, Systemic - drug therapy | Medical colleges | Adults | Systemic scleroderma | Interleukins | Scleroderma (Disease) | Analysis | Tissue | Cytokines | Ulcers | Biomarkers | Fibroblasts | Clinical trials | Patient safety | Skin diseases | Skin | Health risk assessment | Scleroderma | Drug therapy | Pathogenesis | Interleukin | Evidence-based medicine | Itching | Interleukin 6 | Cost-benefit analysis | Safety | Thickening | Effectiveness | Mortality | Lung diseases | Medical treatment | Rheumatology | Patients | Studies | Systemic sclerosis | Least squares | Autoimmune diseases
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2010, Volume 107, Issue 29, pp. 13028 - 13033
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2013, Volume 72, Issue 10, pp. 1613 - 1620
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 2014, Volume 73, Issue 2, pp. 328 - 335
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 08/2017, Volume 69, Issue 8, pp. 1512 - 1516
Journal Article
Journal Article